Light Zinc Injection (Zinc Sulfate Heptahydrate)

Adult dosage

Metabolically stable TPN patients: 2.5 to 4 mg/day Adult patients with fluid loss from the small intestine: an additional 12.2 mg/L (amount of fluid loss) or an additional 17.1 mg/kg (amount of excretion) Acute burn status: 4.5 to 6 mg/day To be used according to a doctor's prescription while monitoring plasma trace mineral levels for dosage adjustment.

Children's dosage

Children under 5 years: 100 ug/kg/day For infants weighing less than 3 kg: 300 ug/kg/day

This drug should not be injected directly into peripheral veins without dilution. This is because administering in this manner can cause venous inflammation or increase the loss of zinc through the kidneys. The amount of zinc contained in this drug is very small, so toxic symptoms rarely appear. When mixing this drug with TPN (total parenteral nutrition) solution, it is advisable to prepare it in a special environment to maintain sterility. Additionally, before injection, the solution must be visually checked for any precipitate or discoloration. When administering zinc, using it together with copper may reduce the concentration of copper in the blood, so the concentrations of both components should be tested at regular intervals as a reference for dosing. This drug is excreted from the body through the intestines and kidneys, so patients with impaired excretory function should be careful as zinc may accumulate in the body. When administering this drug to pregnant or breastfeeding women, it should only be used if the benefits of treatment outweigh the risks, as its safety has not been fully confirmed. Zinc can pass through the placenta and may be present in breast milk. If zinc is overdosed, severe symptoms such as nausea, vomiting, dehydration, electrolyte imbalance, dizziness, abdominal pain, drowsiness, and ataxia may occur, so caution is advised. This drug should be stored out of the reach of children and kept in its original packaging in a dry place at room temperature. As it does not contain preservatives, any unused portions must be discarded.

Mild side effects

• Nausea
• vomiting
• dehydration
• electrolyte imbalance
• dizziness
• abdominal pain
• drowsiness
• ataxia

This drug must be stored in a sealed container to prevent air and moisture from entering, and the storage temperature should be maintained between 1 and 30 degrees Celsius. This will help maintain the drug's efficacy and safety.

Appearance

A colorless, odorless, transparent liquid in a colorless, transparent vial injection.

Package unit

10 milliliters/vial